Davita Healthcare Partners, Inc. (NYSE:DVA)

CAPS Rating: 5 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.


Player Avatar Bartolomo (< 20) Submitted: 1/3/2013 6:55:50 PM : Outperform Start Price: $55.00 DVA Score: -3.41

Warren Buffett has been buying DVA as though it were a cold Coke on a hot day. Fourth quarter 2012 purchases were at least 3.4 million shares, giving him over 14% of shares outstanding and a 33% increase in his position.

Featured Broker Partners